MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

NCT01970410 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: teriflunomide

Sponsor

Providence Health & Services

Collaborators

[object Object]